Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ReoPro [abciximab] Retavase [reteplase] reperfusion of stroke safety study-imaging evaluation.

Trial Profile

ReoPro [abciximab] Retavase [reteplase] reperfusion of stroke safety study-imaging evaluation.

Phase of Trial: Phase II

Latest Information Update: 20 Sep 2011

At a glance

  • Drugs Reteplase (Primary) ; Abciximab
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Oct 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
    • 16 Jun 2009 Primary outcome ammended as reported by ClinicalTrials.gov.
    • 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top